Home » Stocks » TARO

Taro Pharmaceutical Industries Ltd. (TARO)

Stock Price: $70.40 USD 1.83 (2.67%)
Updated November 27, 1:00 PM EST - Market closed

Stock Price Chart

Key Info

Market Cap 2.69B
Revenue (ttm) 583.10M
Net Income (ttm) -267.91M
Shares Out 38.26M
EPS (ttm) -6.99
PE Ratio n/a
Forward PE 16.05
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 27
Last Price $70.40
Previous Close $68.57
Change ($) 1.83
Change (%) 2.67%
Day's Open 68.54
Day's Range 68.26 - 71.22
Day's Volume 32,446
52-Week Range 53.95 - 99.69

More Stats

Market Cap 2.69B
Enterprise Value 1.65B
Earnings Date (est) Feb 10, 2021
Ex-Dividend Date n/a
Shares Outstanding 38.26M
Float 8.76M
EPS (basic) -7.01
EPS (diluted) -6.99
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 112,764
Short Ratio 5.35
Short % of Float 1.29%
Beta 0.89
PE Ratio n/a
Forward PE 16.05
P/FCF Ratio n/a
PS Ratio 4.62
PB Ratio 1.45
Revenue 583.10M
Operating Income -289.77M
Net Income -267.91M
Free Cash Flow n/a
Net Cash 1.04B
Net Cash / Share 27.24
Gross Margin 68.55%
Operating Margin -49.69%
Profit Margin -45.90%
FCF Margin n/a
ROA 5.07%
ROE -15.08%
ROIC -20.20%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (1)

Buy 1
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

Current: $70.40
Target: 80.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth-3.75%1.21%-24.73%-7.51%10.18%13.65%13.16%23.55%7.4%-
Gross Profit400446464671779677580495366330
Operating Income250298305526617530432332238205
Net Income244282211456541484360266204183
Shares Outstanding38.4638.9940.1641.3042.8342.8344.2844.6844.4744.41
Earnings Per Share6.357.235.2611.0512.6211.318.145.954.594.11
EPS Growth-12.17%37.45%-52.4%-12.44%11.58%38.94%36.81%29.63%11.68%-
Operating Cash Flow272324324438395407358249-181
Capital Expenditures-26.61-27.02-25.81-27.25-18.97-19.78-21.24-9.47--5.86
Free Cash Flow245297298410376387336239-176
Cash & Equivalents1,1091,0491,4231,3871,229920632561334259
Total Debt-----5.8917.8628.6038.9144.69
Net Cash / Debt1,1091,0491,4231,3871,229914615532295214
Book Value2,1041,9062,2052,0671,9311,4121,016886619567
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Taro Pharmaceutical Industries Ltd.
Country Israel
Employees 1,464
CEO Uday Vijaykumar Baldota

Stock Information

Ticker Symbol TARO
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Unique Identifier NYSE: TARO


Taro Pharmaceutical Industries, a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprises allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug store chains, food chains, mass merchandisers, grocery chains, and other direct purchasers and customers, as well as healthcare institutions and private pharmacies. The company was founded in 1959 and is based in Haifa Bay, Israel. Taro Pharmaceutical Industries Ltd. is a subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.